Elevance HealthMEX:ELV 75 Return-on-Tangible-Equity is 160.35% as of Mar. 2026, which is 38% below its 10-year median of 256.65. GuruFocus rates MEX:ELV with a GF Score™ of 75/100 and a GF Value™ of MXN8,845.39 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks better than 66.67% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Elevance Health's annualized net income for the quarter that ended in Mar. 2026 was MXN127,239 Mil. Elevance Health's average shareholder tangible equity for the quarter that ended in Mar. 2026 was MXN79,348 Mil. Therefore, Elevance Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 160.35%.
The historical rank and industry rank for Elevance Health's Return-on-Tangible-Equity or its related term are showing as below:
MEX:ELV'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 138.05 Med: 256.65 Max: 606.94
Current: 138.05
During the past 13 years, Elevance Health's highest Return-on-Tangible-Equity was 606.94%. The lowest was 138.05%. And the median was 256.65%.
MEX:ELV's Return-on-Tangible-Equity is ranked better than 66.67% of 18
companies
in the Healthcare Plans industry
Industry Median: 14.115
vs MEX:ELV: 138.05
Elevance Health (MEX:ELV) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Elevance Health Return-on-Tangible-Equity Related Terms
Elevance Health Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Elevance Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ELV vs CI, HUM, CVS: Return-on-Tangible-Equity Comparison
For the Healthcare Plans subindustry, Elevance Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Return-on-Tangible-Equity vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Elevance Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 160.35% mean?
Elevance Health (MEX:ELV) has a Return-on-Tangible-Equity of 160.35% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Elevance Health and its competitors. This is 38% below median its historical median of 256.65. Over the past decade, Elevance Health's Return-on-Tangible-Equity has ranged from 138.05 to 606.94. According to the industry distribution chart, Elevance Health ranks #6 out of 18 companies in the Healthcare Plans industry, placing it in the top 33.3%.
Is Elevance Health's Return-on-Tangible-Equity too high?
Elevance Health's current Return-on-Tangible-Equity of 160.35% is 38% below median its 10-year median of 256.65. Over the past 10 years, this metric has ranged from a low of 138.05 to a high of 606.94. The Healthcare Plans industry median Return-on-Tangible-Equity is 14.12. Elevance Health's value of 160.35% is 1036% above this industry median. Based on the distribution chart, Elevance Health ranks #6 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Return-on-Tangible-Equity compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #6 out of 18 companies for Return-on-Tangible-Equity. This puts Elevance Health in the upper half of its industry. The industry median Return-on-Tangible-Equity is 14.12. Elevance Health's value of 160.35% is 1036% above this benchmark. Historically, Elevance Health's own Return-on-Tangible-Equity has ranged from 138.05 to 606.94 over the past decade. While the company's 10-year median is 256.65 vs. the industry median of 14.12, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Plans company?
The median Return-on-Tangible-Equity among Healthcare Plans companies is 14.12, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current Return-on-Tangible-Equity of 160.35% is 1036% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Return-on-Tangible-Equity is 14.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Return-on-Tangible-Equity is 160.35%, which is 38% below median its own 10-year median of 256.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,845.39, compared to a current price of MXN7,144.06 — trading 19.2% below its estimated fair value. The current Return-on-Tangible-Equity is 160.35%, which is 38% below median its 10-year median of 256.65 and 1036% above the Healthcare Plans industry median of 14.12. Elevance Health's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Return-on-Tangible-Equity is 160.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN7,144.06 is trading 19.2% below its estimated GF Value™ of MXN8,845.39.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
Return-on-Tangible-Equity: 160.35% (38% below median its 10-year median of 256.65)
GF Value™: MXN8,845.39 vs. price of MXN7,144.06 (19.2% below fair value)
Industry Position: 1036% above the Healthcare Plans median (#6 of 18)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
75GF Score
Get the complete analysis for MEX:ELV
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
